24.69
Indivior Plc (INDV) 最新ニュース
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th - BioSpace
How Indivior PLC stock trades during market volatility2025 Price Action Summary & High Conviction Investment Ideas - newser.com
Can Indivior PLC stock reach $100 price targetJuly 2025 Trends & Safe Entry Zone Tips - newser.com
Q3 2025 Results on Oct. 30 — Indivior to Host Live Webcast; replay available - Stock Titan
How Indivior PLC stock performs in rising dollar environmentJuly 2025 Setups & Weekly Breakout Stock Alerts - newser.com
Indivior (NasdaqGS:INDV): Fresh Clinical Data Prompts a Closer Look at Current Valuation - Yahoo
Indivior Q2 2025 presentation: SUBLOCADE growth drives raised guidance By Investing.com - Investing.com Nigeria
Indivior stock hits 52-week high at 25.1 USD By Investing.com - Investing.com Nigeria
Indivior stock hits 52-week high at 25.1 USD - Investing.com
Using AI based signals to follow Indivior PLCPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment - StreetInsider
Clinical Evidence Supports Rapid SUBLOCADE Induction As A Strategy To Improve Retention In Opioid Use Disorder Treatment - TradingView
Indivior: SUBLOCADE Rapid Induction Raises Retention at 2nd Injection | INDV Stock News - Stock Titan
News impact scoring models applied to Indivior PLCWeekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Using Python tools to backtest Indivior PLC strategiesJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Is Indivior PLC stock reversal real or fake2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Earnings call transcript: Indivior’s Q2 2025 revenue rises, guidance boosted - Investing.com
Earnings call transcript: Indivior’s Q2 2025 revenue rises, guidance boosted By Investing.com - Investing.com Canada
Will Indivior PLC stock deliver long term returnsJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Substance Abuse Treatment Market to Witness Remarkable Growth With Indivior PLC, Pfizer, Inc. - openPR.com
Chart based exit strategy for Indivior PLCEarnings Trend Report & Scalable Portfolio Growth Methods - newser.com
Indivior targets $1.5B peak revenue for Sublocade amid 2025 transition plans - MSN
Will Indivior PLC stock rally after Fed decisionsMarket Weekly Review & Weekly Momentum Picks - newser.com
Will Indivior PLC benefit from macro trendsJuly 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com
Strategies to average down on Indivior PLCJuly 2025 Review & Target Return Focused Picks - newser.com
Indivior PLC stock outlook for YEARTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will Indivior PLC outperform the marketJuly 2025 Action & Expert Curated Trade Setups - newser.com
What indicators show strength in Indivior PLCTrade Analysis Report & Daily Volume Surge Signals - newser.com
U.S. Suboxone Market Set to See Booming Growth 2025-2032 Driven by Key Players like Indivior, Teva, and Alcami - openPR.com
Substance Abuse Treatment Market Size, Growth Analysis 2031 - openPR.com
What the charts say about Indivior PLC today2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Indivior Launches Action Agenda for Business Enhancement - MSN
What analysts say about Indivior PLC stockHigh Dividend Yield Stocks & Big Profit Small Budget - earlytimes.in
Automated trading signals detected on Indivior PLC2025 Short Interest & Daily Volume Surge Trade Alerts - newser.com
Full technical analysis of Indivior PLC stockJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com
Why Indivior PLC stock remains resilient2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
Should you wait for a breakout in Indivior PLC2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Can momentum traders help lift Indivior PLCMarket Risk Report & Fast Moving Stock Watchlists - newser.com
Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M - MSN
US AG stops misleading marketing of unauthorized opioid overdose drug by Indivior - The Pharma Letter
Indivior plans U.S. domicile shift from U.K. to enhance Nasdaq presence - Investing.com Nigeria
大文字化:
|
ボリューム (24 時間):